Jingsong Zhang

机构：Spanish Oncology Genitourinary Group · ORCID：0000-0003-1192-5116

发表论文 339 篇 · 总被引 6805 次 · h-index 34

代表论文

• Phase 2 study of dostarlimab plus niraparib in stage III-IV recurrent or refractory Penile squamous cell carcinoma (2025 · Future Oncology · 被引 3)
• Myosteatosis and Sarcopenic Obesity in Men Receiving Androgen Deprivation Therapy for Prostate Cancer: Rationale for Mechanism-Driven Multimodal Intervention (2026 · Preprints.org)
• Abstract PR005: Mathematical biomarkers enable personalized adaptive therapy based on outcome prediction in prostate cancer (2025 · Cancer Research)
• Figure S1 from A Phase II Study of Durvalumab for Bacillus Calmette-Guerin (BCG) Unresponsive Urothelial Carcinoma In Situ of the Bladder (2025)
• Table S1 from A Phase II Study of Durvalumab for Bacillus Calmette-Guerin (BCG) Unresponsive Urothelial Carcinoma In Situ of the Bladder (2025)
• Movie S1 from Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling Dynamics (2025)